CA2182105A1 - Intermediaires de la chloropyrimidine - Google Patents
Intermediaires de la chloropyrimidineInfo
- Publication number
- CA2182105A1 CA2182105A1 CA002182105A CA2182105A CA2182105A1 CA 2182105 A1 CA2182105 A1 CA 2182105A1 CA 002182105 A CA002182105 A CA 002182105A CA 2182105 A CA2182105 A CA 2182105A CA 2182105 A1 CA2182105 A1 CA 2182105A1
- Authority
- CA
- Canada
- Prior art keywords
- intermediates
- chloropyrimide
- processes
- iii
- aminopurines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000543 intermediate Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 2
- -1 9-substituted-2-aminopurines Chemical class 0.000 abstract 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 238000013160 medical therapy Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/50—Three nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9402161.5 | 1994-02-04 | ||
| GB9402161A GB9402161D0 (en) | 1994-02-04 | 1994-02-04 | Chloropyrimidine intermediates |
| PCT/GB1995/000225 WO1995021161A1 (fr) | 1994-02-04 | 1995-02-03 | Intermediaires de la chloropyrimidine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2182105A1 true CA2182105A1 (fr) | 1995-08-10 |
| CA2182105C CA2182105C (fr) | 2006-07-25 |
Family
ID=36707428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002182105A Expired - Lifetime CA2182105C (fr) | 1994-02-04 | 1995-02-03 | Intermediaires de la chloropyrimidine |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2182105C (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117050024A (zh) * | 2023-10-13 | 2023-11-14 | 苏州开元民生科技股份有限公司 | 一种2-氨基-4,6-二氯-5-甲酰胺基嘧啶的合成方法 |
-
1995
- 1995-02-03 CA CA002182105A patent/CA2182105C/fr not_active Expired - Lifetime
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117050024A (zh) * | 2023-10-13 | 2023-11-14 | 苏州开元民生科技股份有限公司 | 一种2-氨基-4,6-二氯-5-甲酰胺基嘧啶的合成方法 |
| CN117050024B (zh) * | 2023-10-13 | 2024-01-05 | 苏州开元民生科技股份有限公司 | 一种2-氨基-4,6-二氯-5-甲酰胺基嘧啶的合成方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2182105C (fr) | 2006-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL112539A0 (en) | Pyrimidine derivatives and their preparation | |
| CA2201785A1 (fr) | Nouveaux derives d'acide carboxylique, leur preparation et leur utilisation | |
| CA2263561A1 (fr) | Thienopyrimidines | |
| MY115679A (en) | Process for preparing intermediates to florfenicol | |
| AU4525396A (en) | Process for the preparation of perfluorocarbons | |
| CA2311922A1 (fr) | Thienopyrimidines | |
| FI981709L (fi) | Menetelmä 5-substituoitujen 2-amino-4-okso-pyrrolo/2,3-d/-pyrimidiinien valmistamiseksi | |
| ZA983851B (en) | Substituted 3,3-diamino-2-propenenitriles their preparation and use | |
| AU4912090A (en) | Intermediates useful in the synthesis of 2-oxy-4h-3, 1-benzoxazin-4-one derivative | |
| CA2219359A1 (fr) | Derives hydantoine utilises comme produits intermediaires pour principes actifs pharmaceutiques | |
| CA2182105A1 (fr) | Intermediaires de la chloropyrimidine | |
| CA2208630A1 (fr) | 4-amino-2-ureidopyrimidine-5-carboxamides, procedes de preparation, produits pharmaceutiques comprenant ces composes et leur utilisation | |
| AU6922994A (en) | Use of acylcarnitin to treat illnesses caused by aids | |
| IL140786A0 (en) | Process for the preparation of 4,6-disubstituted 2-isocyanatopyrimidines and their use as intermediates for active compound syntheses | |
| CA2208611A1 (fr) | 4-amino-2-ureidopyrimidine-5-carboxamides, procedes de preparation, produits pharmaceutiques comprenant ces composes et leur utilisation | |
| HUT71549A (en) | Process for producing pharmaceutical active 4-hydroxy 1h-pyrazolo [3,4d] pyrimidine of high purity | |
| AU4448497A (en) | Novel 6 or 7 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents | |
| IL111770A0 (en) | Triarylborane derivatives, their preparation and their use as synthesis intermediates | |
| CA2155802A1 (fr) | Enantiomeres purs de pyridylcycloalkylethylamines et leurs sels; methode de preparation | |
| ITMI942632A0 (it) | Procedimento per la preparazione di acido 3 alfa-7 beta-diidrossicolanico di elevata purezza | |
| AU693717B2 (en) | Compounds suitable as intermediates in the preparation of thiophenesulfonylurea derivatives | |
| AU693717C (en) | Compounds suitable as intermediates in the preparation of thiophenesulfonylurea derivatives | |
| PL309329A1 (en) | Novel triazopyrimidones, methods of obtaining them and their application | |
| IT1289503B1 (it) | Procedimento per la preparazione di acido 3 alfa-7 beta- diidrossicolanico di elevata purezza |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |
Effective date: 20150203 |